Table: begin end state 1 28 cytoplasmic 29 50 transmembrane 51 65 non-cytoplasmic 66 89 transmembrane 90 96 cytoplasmic 97 116 transmembrane 117 121 non-cytoplasmic 122 144 transmembrane 145 155 cytoplasmic 156 180 transmembrane 181 185 non-cytoplasmic 186 211 transmembrane 212 263 cytoplasmic 264 284 transmembrane 285 296 non-cytoplasmic 297 320 transmembrane 321 326 cytoplasmic 327 347 transmembrane 348 352 non-cytoplasmic 353 376 transmembrane 377 387 cytoplasmic 388 412 transmembrane 413 418 non-cytoplasmic 419 441 transmembrane 442 454 cytoplasmic
Input: >BPHYT_RS03795 FitnessBrowser__BFirm:BPHYT_RS03795 MSAKPAAAAANVIEVEQVLGETHHPAFQLLLLVLCGLCLVIDGFDAQAMGYVAPSVIGEW HVSKAALGPVFSASLFGMLLGALGLSVLADRIGRRPVLIGSTFFFALSMLATPFVTTIPA LIALRFITGLGLGCIMPNAMALVGEFSTPAHRVKRMMLVSCGFTLGAALGGFISAALIPA YGWRAVFWVGGAVPLLLALAMLVALPESLQFLVLKGRSERALRWLAKFNPALPIDANTRL VVREKGNGGAPVAELFRAGRGPVTLILWAISFMNLIDLYFLSNWLPTVMRDAGYSPSTAV IVGTVLQTGGVVGTLLLGWFIERFGFVRVLFVCFAGAALAVGTIGTVAHALPWLLLVVFA GGFCVVGGQPAVNALAGHFYPTTLRSTGIGWSLGIGRIGSVIGPLIGGQLIALNWSNAAL FHAAALPVLCSALLVIALAAATRQRGQSPEPRTA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server